Vaginal atrophy, also called atrophic vaginitis, affects many women throughout the world, occurring almost always after menopause, but also in all cases where there is a lack of oestrogen, such as after childbirth, during the breastfeeding stage when ovulation is blocked or after an oestrogen-sensitive tumour (such as in the breasts, endometrium or the ovaries) where a chemotherapeutic or surgical “castration” of the menstrual cycle occurs. In these cases the use of hormone replacement therapies, even local or at low dosage, are therefore absolutely contraindicated1. The symptoms related to vaginal atrophy normally begin to appear between the ages of 45 and 55. Unlike other symptoms of menopause, such as the hot flashes which often decrease over time, these usually continue and can worsen as time progresses… Download document
